Li, Q., Sun, Q., Jian, Y., He, J., Zhu, H., Hong, C., . . . Cui, H. (2023). Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer: A multicentre retrospective study. Springer.
Chicago Style (17th ed.) CitationLi, Qi-mei, et al. Efficacy and Safety of Different PD-1 Inhibitors in Combination with Lenvatinib in the Treatment of Unresectable Primary Liver Cancer: A Multicentre Retrospective Study. Springer, 2023.
MLA (9th ed.) CitationLi, Qi-mei, et al. Efficacy and Safety of Different PD-1 Inhibitors in Combination with Lenvatinib in the Treatment of Unresectable Primary Liver Cancer: A Multicentre Retrospective Study. Springer, 2023.
Warning: These citations may not always be 100% accurate.